We serve Chemical Name:2-[bis(2-hydroxyethyl)amino]-N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N-methylacetamide CAS:75616-02-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![2-[bis(2-hydroxyethyl)amino]-N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N-methylacetamide](https://a.dearchem.com/CAS2/75616-02-3.png)
Chemical Name:2-[bis(2-hydroxyethyl)amino]-N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N-methylacetamide
CAS.NO:75616-02-3
Synonyms:Dulozafonum;Dulozafona [Spanish];dulozafone[inn];2-(bis(2-hydroxyethyl)amino)-N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N-methylacetamide;Dulozafonum [Latin];Dulozafona;Dulozafone
Molecular Formula:C20H22Cl2N2O4
Molecular Weight:425.30600
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:629.3ºC at 760 mmHg
Density:1.365g/cm3
Index of Refraction:1.625
PSA:81.08000
Exact Mass:424.09600
LogP:2.47380
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Dulozafonum chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Dulozafone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Dulozafonum Use and application,dulozafone[inn] technical grade,usp/ep/jp grade.
Related News: “It’s truly an important scientific issue and important public health issue and FDA is actively exploring all regulatory options for providing access to additional doses of authorized vaccines in situations where data suggests the benefits would outweigh the risks,” Fink said. Dithiophosphoric acid O,O’-dimethyl ester S-pyridin-2-ylmethyl ester manufacturers (For more on Stevanato, see The Covid Vaccine Will Require Billions Of Tiny Glass Vials—And This Italian Billionaire Family Is Making Them.) (R)-2-Benzyloxycarbonylamino-3-(hydroxy-phenyl-methyl)-succinic acid 1-tert-butyl ester suppliers Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial. 4-Methylsulfanyl-3-phenyl-4-(toluene-4-sulfonyl)-butyric acid ethyl ester vendor & factory.
